DEVICETALKS
Hologic CEO sees women's health data making a global impact The company is working with Gallup on a survey to build a wider snapshot of healthcare delivery to women. To m S a l e m i | D e v i c e Ta l k s E d i t o r i a l Director |
62
Medical Design & Outsourcing
H
ologic emerged two decades ago as a potential leader in women’s health products and fulfilled that promise with timely acquisitions and effective device and diagnostics product releases. But CEO Stephen P. MacMillan believes the company hasn’t made its biggest impact yet. In an interview with the DeviceTalks Weekly podcast, MacMillan said Hologic’s decision to partner with the global analytics and polling company Gallup to create the Global Women’s Health Index may be the most important contribution the company can make. “For all the products we’ve made over our company’s lifetime — 3D mammography, the PAP test or HPV test and everything else — the data we get from this [survey] may turn out to have the biggest impact on human health of anything we’ve ever done,” MacMillan said. 5 • 2021
The survey launched last year during the COVID-19 lockdown. MacMillan said Hologic never considered pulling out of the partnership or reducing funding when the pandemic created uncertainty. “This was a commitment we made,” he said. “We wanted to start because we just don’t think there’s enough information about women’s health.” Gallup delivered its survey questions in over 40 different languages to more than 100,000 women and men living in 116 countries, according to the company. The 232,000 minutes of conversation produced 36 million data points. The survey doesn’t focus only on areas where Hologic has products but instead tries to build a wider snapshot of the healthcare delivered to women, according to MacMillan. Hologic’s offerings include diagnostics and treatment in breast health,
www.medicaldesignandoutsourcing.com
Images courtesy of Adobe Stock
